607911354	607911354	CD	B-NP	O
|	|	NN	I-NP	O
CCHH	CCHH	NN	I-NP	O
|	|	NN	I-NP	O
59684211	59684211	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
793855	793855	CD	B-NP	O
|	|	CC	I-NP	O
7/5/1996	7/5/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/10/1996	5/10/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/23/1996	3/23/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
HEMOPTYSIS	HEMOPTYSIS	NN	B-NP	O
.	.	.	O	O

SIGNIFICANT	SIGNIFICANT	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

SINUSITIS	SINUSITIS	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
TRANSPLANTATION	TRANSPLANTATION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
gentleman	gentleman	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
transplant	transplant	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
11/27	11/27	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Nasstrict	Nasstrict	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hemoptysis	hemoptysis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
for	for	IN	B-PP	O
severe	severe	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
rather	rather	RB	I-NP	O
unremarkable	unremarkable	JJ	I-NP	O
course	course	NN	I-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
graft	graft	NN	I-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
last	last	JJ	B-NP	B-protein
catheterization	catheterization	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
from	from	IN	B-PP	O
11/17/96	11/17/96	CD	B-NP	O
to	to	TO	B-PP	O
6/24/96	6/24/96	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
month	month	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sputum	sputum	NN	B-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
cefotaxime	cefotaxime	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
was	be	VBD	B-VP	O
adjusted	adjust	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
problems	problem	NNS	I-NP	O
subsequently	subsequently	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
showed	show	VBD	B-VP	O
prior	prior	JJ	B-NP	O
granulomatous	granulomatous	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
AFB	AFB	NN	B-NP	O
times	time	NNS	I-NP	O
three	three	CD	B-NP	O
done	do	VBN	B-VP	O
:	:	:	O	O
all	all	DT	B-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
Mycobacterium	Mycobacterium	NN	B-NP	O
avium	avium	NN	I-NP	O
grow	grow	VB	B-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
organism	organism	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
pathogen	pathogen	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
persistent	persistent	JJ	B-NP	O
ear	ear	JJ	I-NP	O
fullness	fullness	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
thick	thick	JJ	I-NP	O
,	,	,	O	O
but	but	CC	O	O
clear	clear	JJ	B-NP	O
,	,	,	I-NP	O
nasal	nasal	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
associated	associate	VBN	I-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
was	be	VBD	B-VP	O
blood	blood	NN	I-VP	O
tinged	tinge	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
subsequently	subsequently	RB	B-ADVP	O
coughed	cough	VBD	B-VP	O
up	up	RP	B-PRT	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
quarter	quarter	NN	I-NP	O
cup	cup	NN	I-NP	O
of	of	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
witnessed	witness	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
more	more	JJR	I-NP	O
hemoptysis	hemoptysis	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
amount	amount	NN	I-NP	I-protein
not	not	RB	O	I-protein
documented	document	VBN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
-LRB-	-LRB-	HYPH	B-VP	B-protein
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
hours	hour	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
in	in	IN	B-PP	O
1991	1991	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
ischemic	ischemic	JJ	B-NP	B-protein
cardiomyopathy	cardiomyopathy	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
ankle	ankle	NN	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
goring	gore	VBG	I-VP	O
by	by	IN	B-PP	O
bull	bull	NN	B-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
laceration	laceration	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Peripheral	Peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cyclosporine	Cyclosporine	NN	B-NP	B-protein
125	125	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Cardizem	Cardizem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Imuran	Imuran	IN	B-PP	O
175	175	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
in	in	IN	B-PP	O
Jo	Jo	NNP	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
janitor	janitor	NN	I-NP	O
until	until	IN	B-PP	O
1/19	1/19	CD	B-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
smoked	smoke	VBD	B-VP	O
a	a	DT	B-NP	O
half	half	JJ	I-NP	O
pack	pack	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
times	time	NNS	I-NP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
drinks	drink	VBZ	B-VP	O
only	only	RB	B-ADVP	O
socially	socially	RB	B-ADJP	O
-LRB-	-LRB-	HYPH	I-ADJP	O
occasionally	occasionally	RB	B-ADJP	O
-RRB-	-RRB-	JJ	I-ADJP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NNP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
78	78	CD	I-NP	O
.	.	.	O	O

Mother	Mother	RBR	B-ADJP	O
alive	alive	JJ	I-ADJP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
vitals	vital	NNS	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
was	be	VBD	B-VP	O
97.9	97.9	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/100	160/100	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
bed	bed	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
normocephalic	normocephalic	JJ	B-ADJP	O
,	,	,	O	O
atraumatic	atraumatic	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscles	muscle	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
7	7	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
SMA-7	SMA-7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
glucose	glucose	NN	B-NP	B-protein
284	284	CD	I-NP	I-protein
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.2	1.2	CD	I-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
35.2	35.2	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
platelets	platelet	NNS	B-NP	B-cell_type
191	191	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
was	be	VBD	B-VP	O
13	13	CD	B-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
28.2	28.2	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
Mo	Mo	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
,	,	,	O	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
,	,	,	O	O
bronchoscopy	bronchoscopy	NN	B-NP	O
on	on	IN	B-PP	O
4/3/96	4/3/96	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
bronchiectasis	bronchiectasis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	B-protein
segment	segment	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
CT	CT	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
-RRB-	-RRB-	NNP	B-NP	O
.	.	.	O	O

Purulent	Purulent	JJ	B-NP	O
secretions	secretion	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
encountered	encounter	VBN	I-VP	O
and	and	CC	O	O
sent	send	VBN	B-VP	O
for	for	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
malignancy	malignancy	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
team	team	NN	I-NP	O
did	do	VBD	B-VP	O
recommend	recommend	VB	I-VP	O
starting	start	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
for	for	IN	B-PP	O
MAI	MAI	NN	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
clarithromycin	clarithromycin	NN	B-NP	O
and	and	CC	I-NP	O
ethambutol	ethambutol	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
effect	effect	VBP	B-VP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
cytochrome	cytochrome	NN	I-NP	O
P450	P450	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cyclosporine	cyclosporine	NN	I-NP	O
dose	dose	NN	I-NP	O
required	require	VBD	B-VP	O
adjustment	adjustment	NN	B-NP	O
downward	downward	RB	B-ADVP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
his	his	PRP$	B-NP	O
levels	level	NNS	I-NP	O
200-300	200-300	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
CT	CT	NN	B-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
maxillofacial	maxillofacial	JJ	I-NP	O
area	area	NN	I-NP	O
on	on	IN	B-PP	O
9/12/96	9/12/96	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
scan	scan	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
air	air	NN	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
maxillary	maxillary	JJ	I-NP	O
sinuses	sinus	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
sphenoid	sphenoid	JJ	I-NP	O
sinuses	sinus	NNS	I-NP	O
.	.	.	O	O

Subtotal	Subtotal	JJ	B-NP	O
opacification	opacification	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ethmoid	ethmoid	JJ	I-NP	B-cell_type
air	air	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
subtotal	subtotal	JJ	B-NP	O
opacification	opacification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mastoid	mastoid	JJ	I-NP	B-cell_type
air	air	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
sinuses	sinus	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
minimally	minimally	RB	I-VP	O
developed	develop	VBN	I-VP	O
;	;	:	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
few	few	JJ	I-NP	B-cell_type
air	air	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
present	present	VBP	B-VP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
complete	complete	JJ	B-NP	O
opacification	opacification	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
impression	impression	NN	I-NP	O
was	be	VBD	B-VP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
sinus	sinus	NN	B-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
otomastoiditis	otomastoiditis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ENT	ENT	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
7/24/96	7/24/96	CD	B-NP	O
;	;	:	O	O
their	their	PRP$	B-NP	O
recommendations	recommendation	NNS	I-NP	O
included	include	VBD	B-VP	O
Biaxin	Biaxin	NN	B-NP	B-protein
times	time	NNS	I-NP	I-protein
four	four	CD	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
-LRB-	-LRB-	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
of	of	IN	B-PP	O
MAI	MAI	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
team	team	NN	I-NP	O
recommends	recommend	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
repeat	repeat	NN	I-NP	O
AFBs	AFB	NNS	I-NP	O
be	be	VB	B-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
,	,	,	O	O
clarithromycin	clarithromycin	NN	B-NP	O
and	and	CC	I-NP	O
ethambutol	ethambutol	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
after	after	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
versus	versus	IN	B-PP	O
18-24	18-24	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
team	team	NN	I-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Albuterol	Albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
inhalers	inhaler	NNS	I-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
lowering	lower	VBG	B-VP	O
agent	agent	NN	B-NP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
next	next	JJ	I-NP	O
Transplant	Transplant	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
visit	visit	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LDL	LDL	NN	I-NP	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
151	151	CD	B-NP	O
after	after	IN	B-SBAR	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
discharge	discharge	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Procardia	Procardia	NNP	B-NP	O
XL	XL	NNP	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
ethambutol	ethambutol	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
metered	meter	VBD	B-VP	O
dose	dose	NN	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
175	175	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
clarithromycin	clarithromycin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Afrin	Afrin	NN	B-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
n.a.	n.a.	RB	B-ADVP	O
b.i.d.	b.i.d.	VBP	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Ocean	Ocean	NNP	B-NP	O
Spray	Spray	NNP	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
n.a.	n.a.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
:	:	:	O	O
Fair	Fair	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
To	To	TO	B-VP	O
home	home	VB	I-VP	O
,	,	,	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Transplant	Transplant	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
8/26/96	8/26/96	CD	B-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	I-VP	O
arrange	arrange	VB	I-VP	O
a	a	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gullace	Gullace	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
cyclosporine	cyclosporine	NN	B-NP	O
levels	level	NNS	I-NP	O
monitored	monitor	VBD	B-VP	O
carefully	carefully	RB	B-ADVP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
THOMAS	THOMAS	NNP	B-NP	O
S.	S.	NNP	I-NP	O
KRITZER	KRITZER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ZX68	ZX68	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MONROE	MONROE	NNP	B-NP	O
T.	T.	NNP	I-NP	O
YONTS	YONTS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GW77	GW77	NNP	I-NP	O
GL056/9953	GL056/9953	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
39037	39037	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

W7AWQAETN	W7AWQAETN	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/4/96	7/4/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/17/96	9/17/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

JARROD	JARROD	NNP	B-NP	O
G.	G.	NNP	I-NP	O
SPINDLER	SPINDLER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GW77	GW77	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

FLORENTINO	FLORENTINO	NNP	B-NP	O
G.	G.	NNP	I-NP	O
MESITI	MESITI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O

